Clinical Trial Update: Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating the combination of palliative radiation and pembrolizumab for unresectable metastatic stage IV breast cancer, and it is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: University of Louisville | Conditions: Metastatic Breast Cancer | Phase 2 | Status: RECRUITING